Physician profile
Larry Jay Slomowitz
NPI 1417145525
$1,419.41
in general payments reported to CMS, 2019-2025
12 companies · $125 in 2025
The $125 reported for 2025 was less than what a typical Foot Surgery provider received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $25.72 · 2020: $76.66 · 2021: $350 · 2022: $176 · 2023: $283 · 2024: $383 · 2025: $125.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $790.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $790.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $176.29 | 2022 | |
| Acera Surgical, INC. | $158.17 | 2023 | Restrata Wound Matrix |
| Linvatec Corporation | $155.09 | 2024 | Biobrace 23mm |
| Smith+Nephew, INC. | $125.00 | 2021 | |
| Paratek Pharmaceuticals, INC. | $124.87 | 2025 | Nuzyra |
| Abbvie INC. | $124.45 | 2023 | Dalvance |
| Amgen INC. | $118.80 | 2024 | Krystexxa |
| Horizon Therapeutics Plc | $114.99 | 2021 | |
| Bioventus LLC | $110.46 | 2021 | |
| Stryker Corporation | $108.91 | 2024 | Prostep |
| Cardiovascular Systems INC. | $76.66 | 2020 | |
| Orthofix Medical, INC. | $25.72 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Larry Slomowitz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.